These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18816769)

  • 41. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study.
    Pagoldh M; Hultgren E; Arnell P; Eriksson A
    Scand J Gastroenterol; 2013 Sep; 48(9):1033-40. PubMed ID: 23879825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ulcerative colitis: history of a successful treatment.
    Lago P
    BioDrugs; 2010 Dec; 24 Suppl 1():34-6. PubMed ID: 21175235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.
    Deiana S; Bagnoli S; Manetti N; Caini S; Giannotta M; Scaringi S; Annese V
    Dig Liver Dis; 2016 Dec; 48(12):1432-1437. PubMed ID: 27553087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis.
    Izzo R; Figliuzzi MM; Monteleone G
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1137-1139. PubMed ID: 27494562
    [No Abstract]   [Full Text] [Related]  

  • 45. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ulcerative colitis with low-grade dysplasia.
    Bernstein CN
    Gastroenterology; 2004 Sep; 127(3):950-6. PubMed ID: 15362049
    [No Abstract]   [Full Text] [Related]  

  • 48. Extensive colonic mucosal defect induced by mesalamine.
    Kato J; Yoshida T; Kitano M
    Dig Endosc; 2018 May; 30(3):390-391. PubMed ID: 29469941
    [No Abstract]   [Full Text] [Related]  

  • 49. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
    Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
    J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current management of severe ulcerative colitis.
    Caprilli R; Viscido A; Latella G
    Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
    Dean KE; Hikaka J; Huakau JT; Walmsley RS
    J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of acute severe ulcerative colitis in children.
    Siow VS; Bhatt R; Mollen KP
    Semin Pediatr Surg; 2017 Dec; 26(6):367-372. PubMed ID: 29126505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical and medical treatment in patients with acute severe ulcerative colitis.
    Fornaro R; Caratto M; Barbruni G; Fornaro F; Salerno A; Giovinazzo D; Sticchi C; Caratto E
    J Dig Dis; 2015 Oct; 16(10):558-67. PubMed ID: 26315728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysplastic lesions in ulcerative colitis: changing paradigms.
    Allen PB; Kamm MA; De Cruz P; Desmond PV
    Inflamm Bowel Dis; 2010 Nov; 16(11):1978-83. PubMed ID: 20803510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
    Adam B; Liebregts T; Holtmann G
    Z Gastroenterol; 2006 Mar; 44(3):267-9. PubMed ID: 16514573
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of extended ulcerative colitis (severe colitis excluded)].
    Beaugerie L; Blain A; Brazier F; Gornet JM; Parc Y
    Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 2):974-83. PubMed ID: 15672569
    [No Abstract]   [Full Text] [Related]  

  • 58. An update on anti-TNF agents in ulcerative colitis.
    Samaan MA; Bagi P; Vande Casteele N; D'Haens GR; Levesque BG
    Gastroenterol Clin North Am; 2014 Sep; 43(3):479-94. PubMed ID: 25110254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A.
    Dittrich K; Richter M; Rascher W; Köhler H
    Inflamm Bowel Dis; 2008 Oct; 14(10):1466-7. PubMed ID: 18421764
    [No Abstract]   [Full Text] [Related]  

  • 60. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
    Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.